AGP Executive Report
Last update: 8 hours agoDrug Approval: Takeda won FDA approval for an orexin agonist for type 1 narcolepsy, the first approved drug in this class, as rivals advance competing candidates. Heart Care: A Mount Sinai trial found that combining two calcium-removal techniques before stenting produced a 19% larger stent area than one technique alone. Separately, Anteris reported promising 30-day valve results in 22 patients with severe aortic stenosis. Health Industry Investment: Cambrex broke ground on a $120 million pharmaceutical manufacturing expansion in Iowa, while health-finance startup Midstream Health raised $20 million to grow its AI platform for hospital revenue operations. Diagnostics: HK inno.N partnered with Roche Diagnostics Korea to distribute a rapid testing platform for diabetes and cardiovascular risk in South Korea.Health Access: Vietnam extended its police emergency hotline to coordinate medical dispatch nationwide, a step toward addressing limited access to ambulance care.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
